NCT01462136View on ClinicalTrials.gov

PK Study of ACHN-490 Injection in Renally Impaired Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Conditions
Renal Insufficiency
Interventions
DRUG

ACHN-490 Injection

7.5 mg/kg single dose administered intravenously over 30 minutes

Sponsors

Lead Sponsor

Achaogen, Inc.
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Achaogen, Inc.

INDUSTRY

NCT01462136 - PK Study of ACHN-490 Injection in Renally Impaired Subjects | Biotech Hunter | Biotech Hunter